(ICCC)

Role: President and CEO, Director
Signature: /s/ Timothy C. Fiori Attorney-in-Fact
Issuer symbol: ICCC
Transactions as of: 27 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 29 Jan 2026, 11:40:06 UTC
Previous filing: 04 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
te Boekhorst Paul Francis Olivier	President and CEO, Director	C/O IMMUCELL CORPORATION, 56 EVERGREEN DRIVE, PORTLAND	/s/ Timothy C. Fiori Attorney-in-Fact	29 Jan 2026	0002095704

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ICCC	Stock Options (right to buy)	Award	$0	+110,000		$0.000000	110,000	27 Jan 2026	Common Stock	110,000	$6.26	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Option grant made to Mr. te Boekhorst in connection with his employment as President and CEO. The option shall be treated as an incentive stock option to the maximum extent permitted by the Internal Revenue Code of 1986, as amended, with the balance treated as nonqualified stock option. One hundred percent of the stock option will vest when the Issuer's net operating income for four consecutive calendar quarters equals or exceeds 300% of the Issuer's audited net operating income for its 2025 fiscal year.

Content

Option grant made to Mr. te Boekhorst in connection with his employment as President and CEO. The option shall be treated as an incentive stock option to the maximum extent permitted by the Internal Revenue Code of 1986, as amended, with the balance treated as nonqualified stock option. One hundred percent of the stock option will vest when the Issuer's net operating income for four consecutive calendar quarters equals or exceeds 300% of the Issuer's audited net operating income for its 2025 fiscal year.